Trials / Conditions / Refractory Generalized Myasthenia Gravis
Refractory Generalized Myasthenia Gravis
3 registered clinical trials studyying Refractory Generalized Myasthenia Gravis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | An Exploratory Clinical Study of GC012F Injection for Refractory gMG NCT06419166 | Zhejiang University | EARLY_Phase 1 |
| Completed | Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthen NCT02301624 | Alexion Pharmaceuticals, Inc. | Phase 3 |
| Completed | Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) NCT01997229 | Alexion Pharmaceuticals, Inc. | Phase 3 |